Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6190| Title: | Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (ITD) in Relapsed/Refractory Myeloma: Planned Preliminary Analysis | Authors: | Craig Wallington-Gates | Issue Date: | 2018 | Source: | Blood, 2018 | Journal Title: | Blood | DOI: | 10.1182/blood-2018-99-118172 | metadata.dc.rights.holder: | Craig Wallington-Gates | Type: | Article |
| Appears in Sites: | Sunshine Coast HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.